Assets Held for Sale

9 Months Ended

Sep. 30, 2011

Assets Held for Sale [Abstract]

Disclosure of Long Lived Assets Held-for-sale [Table Text Block]

Assets Held for Sale

In September 2011, the Company's management and Board of Directors made the decision to sell a small product line to focus the Company's operations on its core products in vascular therapy, oncology and critical care applications. In September 2011, $1.7 million in intangible assets and less than $0.1 million of fixed assets became classified as assets held for sale. The Company's management expects the sale of these assets to be completed in the fourth quarter of 2011.